Immuneering Corp's Brett Matthew buys 2298 shares at $4.57/share on Jan 15, 2026.

viernes, 16 de enero de 2026, 4:13 pm ET1 min de lectura
IMRX--

Immuneering Corp (IMRX) has recently announced that Brett Matthew Hall, Chief Scientific Officer, has made a notable investment in the company. On January 15, 2026, Hall purchased 2,298 shares at a price of $4.57 per share. This significant transaction reflects Hall's confidence in the company's future prospects and demonstrates his commitment to its growth and success.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios